These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2192850)

  • 41. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 42. Initial management of glycemia in type 2 diabetes.
    Banarer S
    N Engl J Med; 2003 Feb; 348(8):760-1; author reply 760-1. PubMed ID: 12594327
    [No Abstract]   [Full Text] [Related]  

  • 43. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patients: response to Rosenstock et al.
    Hamid Z; Simmons DL
    Diabetes Care; 2006 Oct; 29(10):2331; author reply 2332. PubMed ID: 17003324
    [No Abstract]   [Full Text] [Related]  

  • 44. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Medication use in diabetes mellitus (VI). Economics and effectiveness of insulin and sulfonyl-urea combination therapy compared with conventional two daily doses].
    Costa B; Estopá A; Borrás J; Sabaté A
    Med Clin (Barc); 1998 Nov; 111(15):568-72. PubMed ID: 9859089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complementing insulin therapy to achieve glycemic control.
    Barnett AH
    Adv Ther; 2013 Jun; 30(6):557-76. PubMed ID: 23797471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intensive insulin therapy in insulin dependent diabetes and combination therapy.
    Spollett GR
    Nurse Pract; 1993 Jul; 18(7):27-8, 33, 36-8. PubMed ID: 8351084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of non-insulin-dependent diabetes mellitus.
    Williams G
    Lancet; 1994 Jan; 343(8889):95-100. PubMed ID: 7903785
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of diabetic nephropathy--control of blood glucose].
    Nishishita S; Shikata K; Makino H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():384-8. PubMed ID: 15999739
    [No Abstract]   [Full Text] [Related]  

  • 50. New agents available for the treatment of diabetes.
    Miller EC
    Home Care Provid; 1996; 1(6):312-4. PubMed ID: 9188302
    [No Abstract]   [Full Text] [Related]  

  • 51. [Short-term intensive insulin therapy as a method of overcoming secondary failure of sulfonylureas in patients with type 2 diabetes (non-insulin-dependent)].
    Jedynasty K; Kasperska-Czyzykowa T; Stepień K; Nowaczyk R
    Pol Arch Med Wewn; 1998 Jun; 99(6):442-51. PubMed ID: 10085698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacologic treatment options for non-insulin-dependent diabetes mellitus.
    Tan GH; Nelson RL
    Mayo Clin Proc; 1996 Aug; 71(8):763-8. PubMed ID: 8691897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Indications and methods of treatment with sulfonylureas in NIDDM patients].
    Cortinovis A; Crippa A
    Minerva Med; 1991 Dec; 82(12):833-40. PubMed ID: 1780090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Sulfonylurea drug--a new sulfonylurea drug for type 2 diabetes].
    Toyota T
    Nihon Rinsho; 1999 Mar; 57(3):695-701. PubMed ID: 10199156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe hypoglycaemia the "tip of the iceberg": an underestimated risk in both type 1 and type 2 diabetic patients.
    Halimi S
    Diabetes Metab; 2015 Apr; 41(2):105-6. PubMed ID: 25824635
    [No Abstract]   [Full Text] [Related]  

  • 56. [Knack of treatment with oral hypoglycemic drugs in the elderly].
    Komatsu M; Hashizume K
    Nihon Rinsho; 2006 Jan; 64(1):93-8. PubMed ID: 16408454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent advances in diabetes care and management.
    Figge J; Figge HL
    Clin Orthop Relat Res; 1993 Nov; (296):31-6. PubMed ID: 8222444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetes beyond insulin: review of new drugs for treatment of diabetes mellitus.
    Modi P
    Curr Drug Discov Technol; 2007 Jun; 4(1):39-47. PubMed ID: 17630927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective.
    Holman RR
    Metabolism; 2006 May; 55(5 Suppl 1):S2-5. PubMed ID: 16631806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sulfonylureas in the treatment of diabetes mellitus--1985.
    Gerich JE
    Mayo Clin Proc; 1985 Jul; 60(7):439-43. PubMed ID: 3925246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.